In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Previous studies have independently validated the prognostic relevance of residual cancer burden (RCB) after neoadjuvant chemotherapy. We used results from several independent cohorts in a pooled ...

Despite decreased incidence rates in average-age onset patients in high-income economies, colorectal cancer is the third most diagnosed cancer in the world, with increasing rates in emerging economies ...

ATLANTA, Ga. (Atlanta News First) - A breast cancer research study at Emory University is one of thousands paused nationwide after more than $180 million in grants were cut at the start of 2025. Dr.

As attorneys try to free a 6-year-old boy treated for cancer, as well as his mother and sibling, they're challenging the Trump administration’s immigration court arrests.

The toxic fungus Aspergillus flavus—known as the “Pharaoh’s Curse” due to its role in the deaths of archaeologists who opened the Tomb of Tutankhamun in the 1920s—could have cancer ...